Physician profile
Amanda Barrett
NPI 1962559831
$524.57
in general payments reported to CMS, 2019-2025
13 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $65.62 · 2021: $41.72 · 2022: $75.73.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $151.00 | 2019-2022 | |
| Coopersurgical, INC. | $68.01 | 2019-2021 | |
| Duchesnay USA Incorporated | $58.18 | 2019 | |
| Allergan, INC. | $48.61 | 2019 | |
| Avion Pharmaceuticals | $41.95 | 2020-2021 | |
| Mylan Pharmaceuticals INC. | $35.59 | 2019-2020 | |
| Lupin INC. | $27.33 | 2019 | |
| Organon LLC | $23.79 | 2022 | |
| Pfizer INC. | $16.38 | 2022 | |
| Therapeuticsmd, INC. | $16.31 | 2019 | |
| Daiichi Sankyo INC. | $14.82 | 2019 | |
| Vertical Pharmaceuticals, LLC | $11.73 | 2019 | |
| Merck Sharp & Dohme LLC | $10.87 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Barrett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.